Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
The biomarkers of atopy in exhaled breath condensate in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Detection and characterisation of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients Source: Eur Respir J, 58 (2) 2003024; 10.1183/13993003.03024-2020 Year: 2021
Exhaled breath condensate analysis in diagnostics of occupational asthma and rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 619s Year: 2006
Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008
Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 227s Year: 2005
Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018
Biomarkers of COPD severity in expired air condensate Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
The role of galactomannan in exhaled breath condensate in detecting pulmonary aspergillosis in patients with exacerbated COPD Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Endothelin -1 in exhaled breath condensate during omalizumab therapy in patients with severe persistent allergic asthma Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009
Metabolomic analysis of exhaled breath condensate in diagnostics of obstructive airway diseases Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011
Cystenil-leukotrienes as markers of airway inflammation in exhaled breath condensate of asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002
Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Assessing small airways dysfunction in asthma, asthma remission and healthy controls using particles in exhaled air Source: ERJ Open Res, 5 (4) 00202-2019; 10.1183/23120541.00202-2019 Year: 2019
Changes in exhaled breath condensate in asthma and COPD: A full analysis of mass-spectra Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010
Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005